Fate Therapeutics Corp (FATE): Balans kapitallashuviga qarzlar

Fate Therapeutics Inc (FATE) grafik logotipi

Fate Therapeutics, Inc. (FATE) kompaniyasining kunlik narxlar grafigi tirik hujayralarni himoya qilish uchun kriogenik hublar tarmog'i orqali immunoterapiyani ishlab chiqayotgan kompaniyaning dinamikasini aks ettiradi. Biomateriallarning murakkab havo transporti yetkazib berish ishonchliligini ta'minlaydi, garchi bu xarajatlarni oshirsa-da. Hozirda biznes aksiyadorlar kapitaliga tayanadi, chunki daromadli mahsulotlarning yo'qligi moliyaviy inersiyani keltirib chiqaradi va ko'rsatkich 0.48 darajasida turibdi.

Fate Therapeutics, Inc. (FATE) - Balans qiymatiga qarzlar 04.07.2022dan 28.10.2026gacha

Fate Therapeutics Inc (FATE) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Fate Therapeutics, Inc.|FATE - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Fate Pharma|FATE - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Fate Therapeutics|FATE - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati fatetherapeutics.com|FATE - Aktivlarning umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Fate Therapeutics, Inc.|FATE - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Fate Therapeutics Corp|FATE - Kompaniyaning umumiy qarzi|Qarzning balans qiymatiga nisbati Fate Pharma|FATE - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Fate Therapeutics
Kompaniyaning barcha koʻrsatkichlari tahlili:Fate Therapeutics, Inc. FATE
Fate Therapeutics Inc asosiy tovari

Fate Therapeutics, Inc. (FATE) iPSC terapiyalarini ishlab chiqish uchun yuqori xarajatlarga duch kelmoqda, bu esa kompaniyani qarz va kapital o'rtasidagi muvozanat hal qiluvchi bo'lgan kapital tuzilmasiga bog'liq qiladi. Jami majburiyatlarning kitob kapitalizatsiyasiga nisbatini tahlil qilish orqali investorlar biznesning kredit yuklamasi va moliyaviy barqarorligini baholaydilar hamda ushbu grafikdan defolt xavfi darajasini yoki aktivlar qiymatining o'sish potentsialini aniqlash uchun foydalanadilar.

Fate Therapeutics, Inc. kimlar bilan raqobatlashadi

ONC - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati halozyme.com HALO|RVMD: Balans kapitallashuviga qarzlar|AAPG - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar CGON|URGN (UroGen Pharma Corp) - Balans qiymatiga qarzlar|BCAX - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati personalis.com (PSNL)|Erasca (ERAS) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Delcath Systems Inc (DCTH)|YmAbs - Balans kapitallashuviga qarzlar|AURA - Qarzning balans qiymatiga nisbati|Candel - Qarzning balans qiymatiga nisbati|ARAY: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati sellaslifesciences.com SLS|Actuate Therapeutics Inc. (ACTU) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar CTOR (Citius Oncology, Inc)|Balans qiymatiga qarzlar TuHURA|TARA - Balans kapitallashuviga qarzlar|Qarzlarning balans kapitallashuviga nisbati aadibio.com (WHWK)|Balans kapitallashuviga qarzlar TCRX (TScan Therapeutics, Inc.)|CSBR - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati XBiotech USA XBIT|CVM - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar OSTX|Balans qiymatiga qarzlar radiopharmtheranostics.com|ARTV - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Adlai Nortye Limited (ANL)|Qarzning balans qiymatiga nisbati Veru Pharma|Qarzning balans kapitaliga nisbati Tempest Therapeutics Corp (TPST)|Balans kapitallashuviga qarzlar Xilio Therapeutics|Qarzning sof aktivlarga nisbati Renovaro Biosciences RENB|MURA (Mural Bio) - Balans kapitallashuviga qarzlar|KAPA: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati onkuretherapeutics.com OKUR|CytoMed Therapeutics Limited (GDTC) - Qarzning sof aktivlarga nisbati|CRIS (Curis Inc.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar APLM|THAR - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati advanbiomed.com (ADVB)|GNPX: Balans kapitallashuviga qarzlar|CLDI - Balans qiymatiga qarzlar|Sunshine Biopharma, Inc. - Qarzning balans qiymatiga nisbati|Xenetic Biosciences (XBIO) - Balans kapitallashuviga qarzlar|SLRX - Qarzning balans qiymatiga nisbati|Purple Biotech Ltd (PPBT) - Qarzning balans kapitaliga nisbati|AONC: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar BeiGene Ltd|Balans kapitallashuviga qarzlar CKPT (Checkpoint Therapeutics)|Qarzning balans qiymatiga nisbati ELEV (elevationoncology.com)|Qarzning balans kapitallashuviga nisbati ICAD|IKNA - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati Notable Labs Inc. (NTBL)|VIRX - Qarzning sof aktivlarga nisbati|MorphoSys AG - Balans kapitallashuviga qarzlar|NAYA (nayabiosciences.com) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Ascentage Pharma (AAPGV)